These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30274909)

  • 21. Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.
    Li J; Wang S; Qin F; Zhu M; You X; Wu C; Fu F; Yuan J
    Andrologia; 2018 Sep; 50(7):e13051. PubMed ID: 29806152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models.
    Ilg MM; Mateus M; Stebbeds WJ; Milenkovic U; Christopher N; Muneer A; Albersen M; Ralph DJ; Cellek S
    Eur Urol; 2019 Feb; 75(2):329-340. PubMed ID: 30344087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    J Urol; 2003 Jul; 170(1):281-4. PubMed ID: 12796706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Photoinduced Biological Properties of Verteporfin.
    Gibault F; Corvaisier M; Bailly F; Huet G; Melnyk P; Cotelle P
    Curr Med Chem; 2016; 23(11):1171-84. PubMed ID: 26980565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners.
    Goldstein I; Knoll LD; Lipshultz LI; Smith T; Kaufman GJ; McMahon CG
    Sex Med; 2017 Jun; 5(2):e124-e130. PubMed ID: 28395998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Strategies in the Management of Peyronie's Disease (PD)-Results of a Survey of 401 Sexual Medicine Experts Across Europe.
    Porst H; Burri A;
    J Sex Med; 2019 Jun; 16(6):901-908. PubMed ID: 31103483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profibrotic role of myostatin in Peyronie's disease.
    Cantini LP; Ferrini MG; Vernet D; Magee TR; Qian A; Gelfand RA; Rajfer J; Gonzalez-Cadavid NF
    J Sex Med; 2008 Jul; 5(7):1607-22. PubMed ID: 18422491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
    Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
    Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Results of Reconstructive Surgery for Peyronie's Disease.
    Garaffa G; Kuehhas FE; De Luca F; Ralph DJ
    Sex Med Rev; 2015 Apr; 3(2):113-121. PubMed ID: 27784545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
    Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
    Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression in Peyronie's disease.
    Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
    Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of collagenase clostridium histolyticum in Peyronie's disease.
    Peak TC; Mitchell GC; Yafi FA; Hellstrom WJ
    Biologics; 2015; 9():107-16. PubMed ID: 26491251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.
    Traore EJ; Wang W; Yafi FA; Hellstrom WJ
    Ther Adv Urol; 2016 Jun; 8(3):192-202. PubMed ID: 27247629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque.
    Kang DH; Yin GN; Choi MJ; Song KM; Ghatak K; Minh NN; Kwon MH; Seong DH; Ryu JK; Suh JK
    World J Mens Health; 2018 May; 36(2):139-146. PubMed ID: 29706035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
    Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
    J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary Review of Grafting Techniques for the Surgical Treatment of Peyronie's Disease.
    Hatzichristodoulou G; Osmonov D; Kübler H; Hellstrom WJG; Yafi FA
    Sex Med Rev; 2017 Oct; 5(4):544-552. PubMed ID: 28258933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease.
    Davila HH; Ferrini MG; Rajfer J; Gonzalez-Cadavid NF
    BJU Int; 2003 Jun; 91(9):830-8. PubMed ID: 12780843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.